Exceptional Responders, Outliers, and Radical Remissions
J Altern Complement Med
.
2018 Sep/Oct;24(9-10):1014-1015.
doi: 10.1089/acm.2018.0334.
Author
Glenn D Sabin
1
Affiliation
1
FON Therapeutics, Inc. , Silver Spring, MD.
PMID:
30247949
DOI:
10.1089/acm.2018.0334
No abstract available
MeSH terms
Humans
Integrative Oncology
Neoplasms / therapy*
Remission, Spontaneous